Association between osteoporosis under treatment and all-cause and specific-cause mortalities: a nationwide retrospective cohort study in South Korea.

IF 2.4 3区 医学 Q2 ORTHOPEDICS BMC Musculoskeletal Disorders Pub Date : 2025-03-24 DOI:10.1186/s12891-025-08527-w
Hyun Youk, Hee Young Lee, Eun Young Lee, Yoon Ji Kim, Ji Yeong Park, Hyo Geun Choi, Hyun Sik Kim, Jung Woo Lee
{"title":"Association between osteoporosis under treatment and all-cause and specific-cause mortalities: a nationwide retrospective cohort study in South Korea.","authors":"Hyun Youk, Hee Young Lee, Eun Young Lee, Yoon Ji Kim, Ji Yeong Park, Hyo Geun Choi, Hyun Sik Kim, Jung Woo Lee","doi":"10.1186/s12891-025-08527-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite the association between osteoporosis treatment and reduced mortality, evidence on specific-cause mortality is lacking. Therefore, this study explored the association between osteoporosis under treatment and all-cause and specific-cause mortalities using nationwide retrospective cohort data from South Korea.</p><p><strong>Methods: </strong>This study utilized data from the National Health Insurance Service screening cohort of South Korea from 2002 to 2019. Participants with osteoporosis who had undergone treatment at least twice and were diagnosed based on bone densitometry were included. Control groups were matched 1:1 based on age, sex, income, and region. Propensity score overlap weighting was applied to balance covariates. Cox proportional hazards models and Fine-Gray sub-distribution hazard models were used to assess all-cause and specific-cause mortalities across 14 disease categories based on the Korean standard classification of diseases.</p><p><strong>Results: </strong>Finally, 34,181 participants were included in both osteoporosis and control groups. The largest age group was 55-59 years, with a majority of female participants (81.60%). Osteoporosis under treatment was significantly associated with reduced all-cause mortality with consistent results across various demographic and clinical subgroups. Specific-cause mortality analysis revealed lower mortality due to neoplasms and metabolic diseases and higher mortality from respiratory and muscular diseases. However, increased risks of respiratory and muscular disease-related mortality were observed.</p><p><strong>Conclusions: </strong>Osteoporosis treatment was associated with reduced all-cause and specific-cause mortalities, particularly from neoplasms and metabolic diseases. Further studies, particularly randomized controlled trials, are required to confirm these results, establish causality, and explore the medication-specific effects on mortality.</p>","PeriodicalId":9189,"journal":{"name":"BMC Musculoskeletal Disorders","volume":"26 1","pages":"291"},"PeriodicalIF":2.4000,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11931836/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Musculoskeletal Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12891-025-08527-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite the association between osteoporosis treatment and reduced mortality, evidence on specific-cause mortality is lacking. Therefore, this study explored the association between osteoporosis under treatment and all-cause and specific-cause mortalities using nationwide retrospective cohort data from South Korea.

Methods: This study utilized data from the National Health Insurance Service screening cohort of South Korea from 2002 to 2019. Participants with osteoporosis who had undergone treatment at least twice and were diagnosed based on bone densitometry were included. Control groups were matched 1:1 based on age, sex, income, and region. Propensity score overlap weighting was applied to balance covariates. Cox proportional hazards models and Fine-Gray sub-distribution hazard models were used to assess all-cause and specific-cause mortalities across 14 disease categories based on the Korean standard classification of diseases.

Results: Finally, 34,181 participants were included in both osteoporosis and control groups. The largest age group was 55-59 years, with a majority of female participants (81.60%). Osteoporosis under treatment was significantly associated with reduced all-cause mortality with consistent results across various demographic and clinical subgroups. Specific-cause mortality analysis revealed lower mortality due to neoplasms and metabolic diseases and higher mortality from respiratory and muscular diseases. However, increased risks of respiratory and muscular disease-related mortality were observed.

Conclusions: Osteoporosis treatment was associated with reduced all-cause and specific-cause mortalities, particularly from neoplasms and metabolic diseases. Further studies, particularly randomized controlled trials, are required to confirm these results, establish causality, and explore the medication-specific effects on mortality.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
接受治疗的骨质疏松症与全因和特定原因死亡率之间的关系:韩国一项全国性回顾性队列研究。
背景:尽管骨质疏松治疗与降低死亡率之间存在关联,但缺乏具体原因死亡率的证据。因此,本研究利用韩国全国回顾性队列数据,探讨了接受治疗的骨质疏松症与全因和特定原因死亡率之间的关系。方法:本研究利用了2002年至2019年韩国国民健康保险服务筛查队列的数据。接受过至少两次治疗并根据骨密度测定诊断的骨质疏松症患者被纳入研究。对照组根据年龄、性别、收入和地区按1:1匹配。倾向得分重叠加权用于平衡协变量。基于韩国标准疾病分类,采用Cox比例风险模型和细灰亚分布风险模型评估14种疾病类别的全因和特定原因死亡率。结果:最终,34,181名参与者被纳入骨质疏松症组和对照组。最大年龄组为55-59岁,以女性参与者居多(81.60%)。接受治疗的骨质疏松症与降低全因死亡率显著相关,不同人口统计学和临床亚组的结果一致。具体原因死亡率分析显示,肿瘤和代谢性疾病的死亡率较低,呼吸道和肌肉疾病的死亡率较高。然而,观察到呼吸和肌肉疾病相关的死亡风险增加。结论:骨质疏松治疗与全因和特定原因死亡率降低相关,尤其是肿瘤和代谢性疾病。需要进一步的研究,特别是随机对照试验来证实这些结果,确定因果关系,并探索药物对死亡率的特异性影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders 医学-风湿病学
CiteScore
3.80
自引率
8.70%
发文量
1017
审稿时长
3-6 weeks
期刊介绍: BMC Musculoskeletal Disorders is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of musculoskeletal disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The scope of the Journal covers research into rheumatic diseases where the primary focus relates specifically to a component(s) of the musculoskeletal system.
期刊最新文献
Management of older adults consulting in GP surgery practices with back pain in UK Clinical Practice Research Datalink Aurum: population based study. 3D printed microporous titanium prosthesis for single implantation or combined with free flap for infected bone defects in the limbs: a single-center retrospective cohort study. Foot plantar pressure characteristics during standing and gait in adolescents with moderate double-curve adolescent idiopathic scoliosis (Lenke type 3 and type 6): a case-control study. Item-level reanalysis of DASH outcomes after flexor tendon repair using Svensson's non-parametric method. Risk factors for ultrasound-guided closed reduction failure of unstable humeral lateral condylar fractures in children: a retrospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1